Clinical trial
Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With…
NCT00221611 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00221611 |
|---|---|
| Title | Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity |
| Official title | Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebral Palsy |
| Intervention type | Drug |
| Interventions | Administration of intrathecal baclofen |
| Enrollment | 80 |
| Start date | Jan 1, 2000 |
| Completion | Aug 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 28, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: